IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 4347 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Imiquimod - Its role in the treatment of cutaneous malignancies

Bubna Aditya Kumar

Year : 2015| Volume: 47| Issue : 4 | Page no: 354-359

   This article has been cited by
1 Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
Deborah Choe, Dongwon Choi
Frontiers in Oncology. 2023; 13
[Pubmed]  [Google Scholar] [DOI]
2 Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
Olivia M. Chen, Keemberly Kim, Chelsea Steele, Kelly M. Wilmas, Nader Aboul-Fettouh, Carrick Burns, Hung Quoc Doan, Sirunya Silapunt, Michael R. Migden
Cancers. 2022; 14(15): 3720
[Pubmed]  [Google Scholar] [DOI]
3 Extramammary Paget's Disease of genitourinary origin
Vikram M. Narayan, Viraj A. Master
Current Opinion in Urology. 2022; 32(2): 211
[Pubmed]  [Google Scholar] [DOI]
4 Technological aspects of creating neopeptide vaccines
M. V. Dmitrieva, M. A. Baryshnikov?, O. L. Orlova, V. S. Kosorukov
Russian Journal of Biotherapy. 2022; 21(4): 10
[Pubmed]  [Google Scholar] [DOI]
5 Treatment of basal cell carcinoma: An overview
Sheerja Bali, Eman Deif, Asha Rajeev
Journal of Skin and Sexually Transmitted Diseases. 2022; 0: 1
[Pubmed]  [Google Scholar] [DOI]
6 Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
Tianhao Duan, Yang Du, Changsheng Xing, Helen Y. Wang, Rong-Fu Wang
Frontiers in Immunology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
7 A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions
Laura Del Regno, Silvia Catapano, Alessandro Di Stefani, Simone Cappilli, Ketty Peris
American Journal of Clinical Dermatology. 2022;
[Pubmed]  [Google Scholar] [DOI]
8 Extramammary Paget’s disease: Updates in the workup and management
Reza Nabavizadeh, Khushali B. Vashi, Behnam Nabavizadeh, Vikram M. Narayan, Viraj A. Master
Asian Journal of Urology. 2022;
[Pubmed]  [Google Scholar] [DOI]
9 Establishment of an efficacious treatment period for prophylactic treatment of auricular keloid recurrence postexcision using topical imiquimod: A demonstrative case series
Lina Chan, H.L. Greenberg
JAAD Case Reports. 2022;
[Pubmed]  [Google Scholar] [DOI]
10 Local skin reactions and the onset of influenza-like signs and symptoms induced by imiquimod
Neal Bhatia
JAAD International. 2022; 7: 113
[Pubmed]  [Google Scholar] [DOI]
11 Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy
Yu-Han Wen, Po-I Hsieh, Hsin-Cheng Chiu, Chil-Wei Chiang, Chun-Liang Lo, Yi-Ting Chiang
Materials Today Bio. 2022; : 100482
[Pubmed]  [Google Scholar] [DOI]
12 Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments
Eliana B. Souto, Raquel da Ana, Vânia Vieira, Joana F. Fangueiro, João Dias-Ferreira, Amanda Cano, Aleksandra Zielinska, Amélia M. Silva, Rafal Staszewski, Jacek Karczewski
Neoplasia. 2022; 30: 100810
[Pubmed]  [Google Scholar] [DOI]
13 Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy
Veronique Beiss, Chenkai Mao, Steven N. Fiering, Nicole F. Steinmetz
Molecular Pharmaceutics. 2022;
[Pubmed]  [Google Scholar] [DOI]
14 Cutaneous metastasectomy: Is there a role in breast cancer? A systematic review and overview of current treatment modalities
Samantha Huang, Vishwas Parekh, James Waisman, Veronica Jones, Yuan Yuan, Nayana Vora, Richard Li, Jae Jung, Laura Kruper, Farah Abdulla, Yuman Fong, Wai-Yee Li
Journal of Surgical Oncology. 2022;
[Pubmed]  [Google Scholar] [DOI]
15 Toll-like receptor-7 activation in CD8+ T cells modulates inflammatory mediators in patients with rheumatoid arthritis
Nitish Swain, Archana Tripathy, Prasanta Padhan, Sunil K. Raghav, Bhawna Gupta
Rheumatology International. 2022;
[Pubmed]  [Google Scholar] [DOI]
16 A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
Humzah Jamshaid, Fakhar ud Din, Maimoona Malik, Muhammad Mukhtiar, Han Gon Choi, Tofeeq Ur-Rehman, Gul Majid Khan
Scientific Reports. 2022; 12(1)
[Pubmed]  [Google Scholar] [DOI]
17 Current Advances in Hypertrophic Scar and Keloid Management
Natasha Barone, Tyler Safran, Joshua Vorstenbosch, Peter G. Davison, Sabrina Cugno, Amanda M. Murphy
Seminars in Plastic Surgery. 2021; 35(03): 145
[Pubmed]  [Google Scholar] [DOI]
18 Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, Balachandran S. Vinod, Lekshmi R. Nath
Molecular Biology Reports. 2021; 48(12): 8075
[Pubmed]  [Google Scholar] [DOI]
19 Development of bioadhesive polysaccharide-based films for topical release of the immunomodulatory agent imiquimod on oral mucosa lesions
Lucas Garcia Camargo, Paula de Freitas Rosa Remiro, Gabriela Souza Rezende, Stephany Di Carla Santos, Michelle Franz-Montan, Ângela Maria Moraes
European Polymer Journal. 2021; 151: 110422
[Pubmed]  [Google Scholar] [DOI]
20 Ionizing radiation and toll like receptors: A systematic review article
Ali Mehdipour, Aliakbar Yousefi-Ahmadipour, Derek Kennedy, Mohammad Kazemi Arababadi
Human Immunology. 2021; 82(6): 446
[Pubmed]  [Google Scholar] [DOI]
21 Discovery of new TLR7 agonists by a combination of statistical learning-based QSAR, virtual screening, and molecular dynamics
Ardavan Abiri, Masoud Rezaei, Mohammad Hossein Zeighami, Younes Vaezpour, Leili Dehghan, Maedeh KhorramGhahfarokhi
Informatics in Medicine Unlocked. 2021; 27: 100787
[Pubmed]  [Google Scholar] [DOI]
22 Treatment of locally advanced cutaneous Merkel cell carcinoma with topical imiquimod
Komal Saini, Paul Chee
JAAD Case Reports. 2021; 13: 121
[Pubmed]  [Google Scholar] [DOI]
23 Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer
Dilraj Kaur, Chakit Arora, Gajendra Pal Singh Raghava
Molecular Diagnosis & Therapy. 2021; 25(5): 629
[Pubmed]  [Google Scholar] [DOI]
24 Treatment approaches for treating hypertrophic scars and keloids
Chloe Gianatasio, Michael Abrouk, Jill S. Waibel
Dermatological Reviews. 2021; 2(1): 11
[Pubmed]  [Google Scholar] [DOI]
25 A case report of imiquimod topical therapy as treatment for cutaneous metastasis of breast cancer
Anthony L Nguyen, Esther G Chong, Joanne Lee, Saied Mirshahidi, Hamid Mirshahidi
Rare Tumors. 2021; 13: 2036361320
[Pubmed]  [Google Scholar] [DOI]
26 Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid
Martina Ghezzi, Silvia Pescina, Andrea Delledonne, Ilaria Ferraboschi, Cristina Sissa, Francesca Terenziani, Paula De Freitas Rosa Remiro, Patrizia Santi, Sara Nicoli
Pharmaceutics. 2021; 13(9): 1476
[Pubmed]  [Google Scholar] [DOI]
27 Current therapies for actinic keratosis
Caterina Dianzani, Claudio Conforti, Roberta Giuffrida, Paola Corneli, Nicola Meo, Eleonora Farinazzo, Anna Moret, Giovanni Magaton Rizzi, Iris Zalaudek
International Journal of Dermatology. 2020; 59(6): 677
[Pubmed]  [Google Scholar] [DOI]
28 The Next Generation of Pattern Recognition Receptor Agonists: Improving Response Rates in Cancer Immunotherapy
Daniel H. O’ Donovan, Yumeng Mao, Deanna A. Mele
Current Medicinal Chemistry. 2020; 27(34): 5654
[Pubmed]  [Google Scholar] [DOI]
29 Topical treatments for skin cancer
Jason K. Cullen, Jacinta L. Simmons, Peter G. Parsons, Glen M. Boyle
Advanced Drug Delivery Reviews. 2020; 153: 54
[Pubmed]  [Google Scholar] [DOI]
30 Recent advances in localized immunotherapy of skin cancers
Irene Russo, Alvise Sernicola, Mauro Alaibac
Immunotherapy. 2019; 11(5): 443
[Pubmed]  [Google Scholar] [DOI]
31 Black salve treatment of skin cancer: a review
Alvin Lim
Journal of Dermatological Treatment. 2018; 29(4): 388
[Pubmed]  [Google Scholar] [DOI]
32 TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings
Maryam A. Shetab Boushehri, Alf Lamprecht
Molecular Pharmaceutics. 2018; 15(11): 4777
[Pubmed]  [Google Scholar] [DOI]
33 Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments
T. Gracia-Cazaña, S. González, Y. Gilaberte
Actas Dermo-Sifiliográficas (English Edition). 2016; 107(9): 730
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow